In this regard, Ramadan et al [17] demonstrated that insulin resistance was one of the primary mechanisms leading to sleep apnea in rats, and that treatment with metformin, an insulin-sensitizing drug, not only prevented but also reversed apneic episodes. The gene discussed is INS; the disease is sleep apnea syndrome.